Abstract:A few decades ago, drug discovery and development were limited to a bunch of medicinal chemists working in a lab with enormous amount of testing, validations, and synthetic procedures, all contributing to considerable investments in time and wealth to get one drug out into the clinics. The advancements in computational techniques combined with a boom in multi-omics data led to the development of various bioinformatics/pharmacoinformatics/cheminformatics tools that have helped speed up the drug development process. But with the advent of artificial intelligence (AI), machine learning (ML) and deep learning (DL), the conventional drug discovery process has been further rationalized. Extensive biological data in the form of big data present in various databases across the globe acts as the raw materials for the ML/DL-based approaches and helps in accurate identifications of patterns and models which can be used to identify therapeutically active molecules with much fewer investments on time, workforce and wealth. In this review, we have begun by introducing the general concepts in the drug discovery pipeline, followed by an outline of the fields in the drug discovery process where ML/DL can be utilized. We have also introduced ML and DL along with their applications, various learning methods, and training models used to develop the ML/DL-based algorithms. Furthermore, we have summarized various DL-based tools existing in the public domain with their application in the drug discovery paradigm which includes DL tools for identification of drug targets and drug–target interaction such as DeepCPI, DeepDTA, WideDTA, PADME DeepAffinity, and DeepPocket. Additionally, we have discussed various DL-based models used in protein structure prediction, de novo design of new chemical scaffolds, virtual screening of chemical libraries for hit identification, absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction, metabolite prediction, clinical trial design, and oral bioavailability prediction. In the end, we have tried to shed light on some of the successful ML/DL-based models used in the drug discovery and development pipeline while also discussing the current challenges and prospects of the application of DL tools in drug discovery and development. We believe that this review will be useful for medicinal and computational chemists searching for DL tools for use in their drug discovery projects.

Deep Learning Pipeline for Accelerating Virtual Screening in Drug Discovery

Streamlining Computational Fragment-Based Drug Discovery Through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

An artificial intelligence accelerated virtual screening platform for drug discovery

Deep Learning in Virtual Screening: Recent Applications and Developments

Boosting Docking-Based Virtual Screening with Deep Learning

Artificial intelligence-enabled virtual screening of ultra-large chemical libraries with deep docking

Integrative Drug Discovery Platform: A Modular Approach for Efficient and Automated Virtual Screening

Deep Learning Strategies for Enhanced Molecular Docking and Virtual Screening

Exploration on Learning Molecular Docking with Deep Learning Models

Deep learning tools for advancing drug discovery and development

Deep learning in drug discovery: a futuristic modality to materialize the large datasets for cheminformatics

Deep Learning and Virtual Drug Screening

DENVIS: Scalable and High-Throughput Virtual Screening Using Graph Neural Networks with Atomic and Surface Protein Pocket Features

Artificial intelligence: Machine learning approach for screening large database and drug discovery

Ultra‐Large Virtual Screening: Definition, Recent Advances, and Challenges in Drug Design

Deep Surrogate Docking: Accelerating Automated Drug Discovery with Graph Neural Networks

Streamlining Large Chemical Library Docking with Artificial Intelligence: the PyRMD2Dock Approach

A deep learning and docking simulation-based virtual screening strategy enables the rapid identification of HIF-1α pathway activators from a marine natural product database

Deep Learning-Based Construction of a Drug-Like Compound Database and Its Application in Virtual Screening of HsDHODH Inhibitors